Karlsruhe (GER) — German-based joimax^®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF^® Delta-Cage and EndoLIF^® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax^® cages.

“With FDA clearance of two of our cages, our EndoLIF^® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax^® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.

Karlsruhe, Germany – January 17^th, 2017 – the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery joimax^® announces again very satisfying growing sales figures. Record sales in 2016 are representing another 31% growth vs. 2015. This is in line with a Compound Annual Growth Rate (CAGR) from 2007 – 2016 of around 32%. Projections into 2017 show even accelerated growth due to the worldwide increasing adoption rate of the joimax^® procedures.

The company is busy on inventing and innovating next minimally invasive systems with regards to newer implants based on the EndoLIF^® technology but also decompression methods based on its endoscopic systems. This will now be completed with Intracs^®, the new Interaoperative Navigation Tracking & Control System with which joimax^® instruments can be navigated directly at the tip. The Intracs^® Navigation and Monitor Unit is integrated in the joimax^® Endoscopic Tower and all necessary tools are tailored for the TESSYS^® (transforaminal) and iLESSYS^® (interlaminar) procedures as well as for minimally invasive stabilization procedures, like EndoLIF^® (Lumbar Interbody Fusion) and Percusys^® (Percutaneous Screw-Rod Stabilization).

Karlsruhe (GER), 16 June 2020
 joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax^® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

joimax^® is looking forward to working with a partner strong as JMC, says joimax^® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax^®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax^® products in Japan”. Thus, joimax^® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax^® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

IRVINE, CA – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation tower, NAVENTO^® Navigation Endoscopic Tower. Optimized for endoscopic spine surgery with special settings for the safe treatment of sensitive structures, NAVENTO^® will be featured at the North American Spine Society (NASS) meeting in Boston later this month and at EUROSPINE in Vienna this October.

NAVENTO^®, the fully integrated fourth generation endo-tower, contains everything a surgeon needs to perform a successful procedure. The tower boasts updated design features for enhanced usability and is composed of six devices that work in unison to give the user the best possible surgical experience:

1. Vitegra^®, the brain of NAVENTO^®, offers complete documentation and data management.
2. Camsource^® LED provides optimal clarity up to 4K resolution.
3. Intracs^®, the newest device from joimax^®, delivers electromagnetic navigation at the instrument’s tip.
4. Shrill^®, the shaver drill system, with the newest generation recently launched, provides optimal RPMs and torque management.
5. Endovapor^® 2 poses electrosurgical offerings for monopolar and bipolar settings.
6. Versicon^®, delivers fluid and pressure regulation.

“joimax^® continues to lead the endoscopic spine market through innovations in technologies aimed to increase the user experience and provide spinal patients with an ultra-minimally invasive treatment option,” stated Christoph Hofstetter, M.D., Ph.D., associate professor in the Department of Neurological Surgery at the University of Washington.

Wolfgang Ries, CEO and founder of the joimax^® group, confirmed, “NAVENTO^® pulls together the latest technologies forming one complete, seamlessly integrated spinal endoscopic package.”

NAVENTO^®, along with the full suite of joimax^® endoscopic technologies will be showcased at NASS, booth #3512, and at EUROSPINE, booth #04.

Irvine, CA – April 26, 2017 – joimax^®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor^® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax^® Endovapor^® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax^® Vaporflex^® and Legato^® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax^® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax^®.

During the AANS, joimax^®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.

Karlsruhe (GER), 26 June 2020 – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide distributor in Taiwan, Hi-Clearance Inc. With the aim of building an effective, long-term relationship, the strategic supplier partnership is a further milestone in the international growth of joimax^® .

“Hi-Clearance is our ideal sales and service partner,” says joimax^® CEO and Founder Mr. Wolfgang Ries. With their streamlined structure and process in place, we are confident joimax^® will penetrate this new market very successfully”.

Hi-Clearance Inc. has over 239 employees, and is a well-known supplier of medical materials and equipment in Taiwan. “We are very pleased about the new strategic partnership and are excited to continue the strong growth of both companies,” states Hi-Clearance Chairman Mr. John Lee and President Mr. Ernie Chen. “We are dedicated to establishing joimax^® as the leading brand of endoscopic spine surgery in Taiwan.”

Hi-Clearance Inc. is headquartered in Taipei with four other branches spread across the country. The main business includes products for Hemodialysis, Critical Care, Dental, Cardiology, Homecare Devices, Nutrition and a major Spine Surgery Division. In 2019, sales were USD 107 million.

Karlsruhe (GER) / Irvine, CA – December 6, 2018 – joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, is well positioned for Germany’s principal spine convention, German Spine Society (DWG), taking place December 6 to 8 in Wiesbaden, Germany.

This year, joimax^® is focusing on their Endoscopic Tower Generation 4 Devices, an expert solution for spinal surgery. They will showcase the new Camsource^® LED, a fully integrated camera and light source system that delivers brilliant images up to 4K; and the Vitegra^®, the integrated visualization, documentation and commanding device. This marks the global launch of both devices, including in Europe, Asia, and the United States.

Moreover, joimax^® will exhibit its EndoLIF^® product line: the well-known 3D-printed EndoLIF^® O/On-Cage, the EndoLIF^® Delta Cage, and the EndoLIF^® Double Wedge Cage (approval expected shortly).

“The main advantage of the EndoLIF^® Implants is the gentle and atraumatic access via gradual tissue dilatation — muscles remain intact and infection risk is reduced. Using 3D-printing technology, an open diamond cell structure, and a rough and porous surface, leads to optimal bone ingrowth, stability and finally fusion,” states Wolfgang Ries, Founder and CEO of the joimax^® Group. “Even awake, fusion with very fast patient recovery has started to be realized on the base of endoscopic minimally-invasive techniques.”

Additionally, joimax^®  will show Intracs^{® em}, the first complete electromagnetic navigation system for endoscopic minimally invasive spine surgery. Intracs^® is an easy to set up, user-friendly system that can serve as a stand-alone device. It relies on electromagnetic tracking and was designed specifically for simple and safe access to any spinal target. It’s the only device on the market that allows for simultaneous navigation of multiple instruments such as needles, guiding rods, reamers, and endoscopes, also developed by joimax^®.

Besides an expanded booth presence with daily Meet-the-Expert Sessions, joimax^® will again host two lunch symposiums on endoscopic spinal procedures: one covering endoscopic pain therapy, and the other addressing diverse intracanal surgical treatment modalities, including endoscopic fusion.

Karlsruhe (GER) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Australian medical device distributor, LifeHealthcare. The two companies have entered into a long-term relationship to provide a broader surgical choice for patients considering spinal surgery.

“We’re looking forward to working with a partner as strong as LifeHealthcare,” says joimax^® Founder and CEO Wolfgang Ries. “LifeHealthcare shares our goals and vision, ensuring that we are able to deliver the highest standards of patient care.”

Endoscopic spine surgery has been steadily growing in popularity since the late 1990’s with exponential growth in the technique for the past ten years. Surgeons throughout the world have reported that this type of surgery can assist patients in faster recovery, enabling them to reduce their post-operative stay.

“We’re very pleased to collaborate with joimax^®,” comments LifeHealthcare Chief Executive Officer Matt Muscio. “Endoscopic spine surgery is a technique that enables patients to have access to truly minimally invasive surgical procedures of the spine.”

Thus, joimax^® strengthens its sales activities in Australia and enters into another important partnership across APAC.

About LifeHealthcare

LifeHealthcare is a leading independent provider of healthcare solutions in Australia and New Zealand bringing healthcare professionals innovative medical devices by partnering with world class companies who share the vision of innovation and making a real difference to people’s lives. LifeHealthcare has been recognised as one of the Financial Times 1,000 High Growth Companies in Asia-Pacific. In May 2018, LifeHealthcare was acquired by Australia’s largest private equity fund, Pacific Equity Partners, a market leader that has been recognised as a Top 20 Consistent Performer Globally by Prequin. For further information, please visit www.lifehealthcare.com.au.

Baltimore, MD – July 14, 2016– The Centers for Medicare & Medicaid Services (CMS) recently released the proposed rules for the 2017 Medicare Physician Fee Schedule (MPFS) and the 2017 Hospital Outpatient Prospective Payment System (HOPPS). Both proposed rules provide information on physician and hospital payment for the newly created CPT code 630X1 for endoscopic decompression of the lumbar spine.

“This is a great step towards the acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the surgeon and their patients in the U.S.,” said Wolfgang Ries, Founder and CEO of joimax^®. This announcement is in alignment with the reimbursement decision of NICE, UK, in April of 2016, to fully reimburse endoscopic procedures.

A key reason for the recent momentum for endoscopic, minimally invasive spinal surgery is the significant, favorable base of literature, which validates evidence of the efficacy of endoscopic minimally invasive spine surgery. A special edition, “Neurosurgical Focus”, published by the Journal of Neurosurgery (JNS) in February 2016, contains a range of studies on endoscopic spine surgery.